Jynarque — United Healthcare
autosomal dominant polycystic kidney disease (ADPKD)
Initial criteria
- Diagnosis of autosomal dominant polycystic kidney disease (ADPKD)
Reauthorization criteria
- Documentation of positive clinical response to Jynarque therapy
Approval duration
12 months